• en
  • it
  • de
  • Renewed GMP Certificate for our Manufacturing Facility Farmabios in Gropello Cairoli (Italy)

    More News and Fairs

    Breaking News: PharmaZell Group acquired by Bridgepoint

    The PharmaZell Group management is very pleased to inform that the Group was acquired by Bridgepoint from DPE Deutsche Private Equity and Maxburg Capital Partners for an undisclosed sum. Bridgepoint

    Statement regarding supply situation in light of the current Corona Virus outbreak

    To Whom it may concern The Corona Virus outbreak has triggered a number of emergency measures across China, though the Epicenter is only in the Wuhan / Hubei region. Due

    Farmabios Breaks Ground to Expand its Manufacturing Footprint in Gropello Cairoli (Italy)

    As part of an ongoing investment program to enhance PharmaZell Group’s production output, we have initiated the construction of a brand new large steroid building and a new warehouse on

    Renewed GMP Certificate for our Manufacturing Facility Farmabios in Gropello Cairoli (Italy)

    We are very glad to announce that the competent Italian authority (AIFA) has issued a renewed GMP certificate for our Farmabios SpA production facility [http://eudragmdp.ema.europa.eu/inspections/gmpc/generateGMPCPDF.do].

    Farmabios expands its portfolio with Cannabidiol API

    Global API supplier Farmabios announced today the addition of an ultra-pure synthetic Cannabidiol (CBD) drug substance to its portfolio. With an EU Drug Master File and cGMP manufacturing capacities, Farmabios

    Check out our new website!

    We are proud to share our new website with the pharmaceutical industry community.  As the PharmaZell Group has grown in the last ten years, so has our communication needs. We